CME Group Inc. $CME Shares Sold by Vinva Investment Management Ltd

Vinva Investment Management Ltd lessened its stake in shares of CME Group Inc. (NASDAQ:CME) by 33.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,992 shares of the financial services provider’s stock after selling 3,050 shares during the quarter. Vinva Investment Management Ltd’s holdings in CME Group were worth $1,631,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in the company. MBM Wealth Consultants LLC boosted its stake in shares of CME Group by 2.7% during the 2nd quarter. MBM Wealth Consultants LLC now owns 1,422 shares of the financial services provider’s stock worth $392,000 after purchasing an additional 37 shares during the last quarter. West Family Investments Inc. grew its holdings in shares of CME Group by 1.2% during the third quarter. West Family Investments Inc. now owns 3,062 shares of the financial services provider’s stock worth $827,000 after buying an additional 37 shares in the last quarter. Atlatl Advisers LLC raised its position in shares of CME Group by 1.8% in the third quarter. Atlatl Advisers LLC now owns 2,126 shares of the financial services provider’s stock valued at $574,000 after buying an additional 38 shares during the last quarter. Verus Capital Partners LLC lifted its stake in shares of CME Group by 0.6% during the third quarter. Verus Capital Partners LLC now owns 7,025 shares of the financial services provider’s stock valued at $1,898,000 after buying an additional 40 shares during the period. Finally, Finemark National Bank & Trust lifted its stake in shares of CME Group by 0.9% during the third quarter. Finemark National Bank & Trust now owns 4,645 shares of the financial services provider’s stock valued at $1,255,000 after buying an additional 42 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Transactions at CME Group

In other CME Group news, CEO Terrence A. Duffy sold 25,000 shares of the business’s stock in a transaction dated Thursday, December 11th. The stock was sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the completion of the sale, the chief executive officer owned 65,804 shares of the company’s stock, valued at approximately $17,737,468.20. The trade was a 27.53% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Martin J. Gepsman sold 300 shares of the company’s stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $305.90, for a total value of $91,770.00. Following the sale, the director owned 24,999 shares of the company’s stock, valued at $7,647,194.10. This represents a 1.19% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 30,248 shares of company stock valued at $8,355,450 in the last ninety days. Company insiders own 0.30% of the company’s stock.

CME Group Stock Performance

Shares of CME stock opened at $319.09 on Tuesday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.03 and a current ratio of 1.03. The firm has a market capitalization of $115.06 billion, a price-to-earnings ratio of 28.59, a price-to-earnings-growth ratio of 3.69 and a beta of 0.24. CME Group Inc. has a one year low of $248.53 and a one year high of $329.16. The company has a 50 day moving average price of $292.99 and a 200 day moving average price of $278.00.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share for the quarter, beating analysts’ consensus estimates of $2.75 by $0.02. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The company had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter last year, the business earned $2.52 EPS. CME Group’s revenue for the quarter was up 8.1% on a year-over-year basis. Sell-side analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, March 26th. Investors of record on Tuesday, March 10th will be issued a $1.30 dividend. The ex-dividend date is Tuesday, March 10th. This is an increase from CME Group’s previous quarterly dividend of $1.25. This represents a $5.20 dividend on an annualized basis and a yield of 1.6%. CME Group’s payout ratio is 44.80%.

Analyst Upgrades and Downgrades

Several analysts have commented on CME shares. JPMorgan Chase & Co. lifted their target price on shares of CME Group from $262.00 to $266.00 and gave the stock an “underweight” rating in a research note on Thursday, February 5th. UBS Group reissued a “neutral” rating and set a $310.00 price target on shares of CME Group in a research note on Friday, February 6th. Royal Bank Of Canada raised their price objective on CME Group from $295.00 to $302.00 and gave the stock a “sector perform” rating in a report on Thursday, February 5th. Raymond James Financial lowered their price objective on CME Group from $311.00 to $310.00 and set an “outperform” rating for the company in a research report on Wednesday, February 4th. Finally, Weiss Ratings upgraded CME Group from a “buy (b+)” rating to a “buy (a-)” rating in a research note on Monday, March 2nd. Two analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, CME Group presently has a consensus rating of “Hold” and an average price target of $302.71.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.